NovAccess Global Inc. (XSNX)
Sector: Biotechnology
Industry: Biotechnology
NovAccess Global Inc.
OTC:XSNXHealthcare · Biotechnology
$0.0001
CLOSED · Nov 11Prev close$0.0001Close$0.0001
Mkt Cap$6K
EV-
Float26.32M
O/S61.65M
VOL200 sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
MCap$6KFloat26.32MO/S61.65M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 200 |
| Nov 10, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 202 |
| Oct 12, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 158 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells.
The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
Key Metrics
Market Cap$6,165
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 61.65M shares outstanding
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
Country
US
IPO DateSep 21, 1998
Shares Outstanding61.65M
Authorized Shares
Float26.32M
52-Week Range
$0.0001$0.0005
$0.0001(0th percentile)
Volume
Average Daily Volume201
200 today vs 201 avg(-0%)
30d Avg
201
60d Avg
187
90d Avg
2.17K
Earnings
Dividend History
No dividend history available
NovAccess Global Inc. (OTC: XSNX) traded at $0.0001 on Nov 11, 2026. 52-week range: $0.0001 to $0.0005. The company is in the Healthcare sector (Biotechnology).